These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

SYNT-101 offers a novel approach to weight loss by temporarily altering nutrient absorption in the small intestine. Unlike GLP-1 drugs, which are administered via injection and ...

XOMA Royalty sold the remaining Kinnate pipeline assets for a total of up to $270 million in upfront and milestone payments, plus royalties on ...

Germany's three largest political parties have agreed to form a new government, uniting the center-right Christian Democrats ...

A new study identifies a blood-based biomarker that detects pre-symptomatic Parkinson’s disease by measuring the ratio of ...

The glove box market is propelled by increasing demand across industries such as pharmaceuticals, healthcare, semiconductors, ...

Despite a challenging 2024 for Boston’s life sciences market—marked by softening fundamentals and an oversupply of lab ...

Under the agreement, Chromatin Bioscience will use its proprietary chromatinLENS platform to design cell-selective synthetic promoters aligned with Astellas' target profile. The designed promoters are ...

The rise of AI in health care presents new challenges related to the patentability and regulation of AI-driven medical ...

A study reveals that a calorie-restricted Mediterranean diet paired with physical activity preserves bone health in older ...

The share buy-back program is undertaken in accordance with Regulation (EU) No. 596/2014 ('MAR') and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the "Safe Harbour ...

Smartkem , which is seeking to change the world of electronics with a new class of transistor technology, announced it will exhibit and its CEO will give a presentation at Display Week 2025 taking ...